^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:IGEV (gemcitabine + ifosfamide + vinorelbine tartrate)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Hodgkin Lymphoma...Relapsed/Refractory Disease...Second-Line and Subsequent Therapy...IGEV (ifosfamide, gemcitabine, vinorelbine)